<https://rdf.molmedb.upol.cz/reference/ref3017> <http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM488749>;
	<http://purl.org/ontology/bibo/doi> "10.1016/j.bmcl.2015.05.055"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://identifiers.org/molmedb/MM490178>,
		<https://rdf.molmedb.upol.cz/interaction/membrane46>;
	<http://purl.org/dc/terms/bibliographicCitation> "Fauber BP, Gobbi A, Robarge K, Zhou A, Barnard A, Cao J, Deng Y, Eidenschenk C, Everett C, Ganguli A, Hawkins J, Johnson AR, La H, Norman M, Salmon G, Summerhill S, Ouyang W, Tang W, Wong H.: Discovery of imidazo[1,5-a]pyridines and -pyrimidines as potent and selective RORc inverse agonists. Bioorg Med Chem Lett, Volume 25 (15), 2015"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://purl.org/dc/terms/subject> <https://rdf.molmedb.upol.cz/interaction/method71>;
	<http://purl.org/ontology/bibo/pmid> "26048793"^^<http://www.w3.org/2001/XMLSchema#string>;
	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/dc/terms/BibliographicResource> .
<https://rdf.molmedb.upol.cz/interaction/int1009713> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3017> .
<https://rdf.molmedb.upol.cz/interaction/int1007463> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3017> .
<https://rdf.molmedb.upol.cz/interaction/int1007464> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3017> .
<https://rdf.molmedb.upol.cz/interaction/int1009712> <http://www.w3.org/ns/prov#hadPrimarySource> <https://rdf.molmedb.upol.cz/reference/ref3017> .
